Paip1 overexpression is involved in the progression of gastric cancer and predicts shorter survival of diagnosed patients
OncoTargets and Therapy Aug 22, 2019
Wang Q, Han A, Chen L, et al. - A total of 90 gastric cancer (GC) samples and 90 adjacent noncancerous tissues were used to investigate the expression of Paip1 by the researchers in order to discover Paip1 expression levels and examine its underlying molecular mechanism in GC. Paip1 expression was noted to be upregulated in GC and was related to shorter overall survival. Knockdown of Paip1 restricted cell proliferation, migration and led to cell cycle arrest in GC cells, whereas its overexpression reversed these impacts. Another mechanistic study exhibited that Paip1 overexpression promoted epithelial-mesenchymal transition progression and regulated its targets expression. Thus, high expression of Paip1 was concluded to play an important role in the progression of GC and could be a eligible biomarker of poor prognosis as well as a therapeutic target.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries